Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-24-021727
Filing Date
2024-02-13
Accepted
2024-02-13 17:12:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G tv01713-plianttherapeuticsin.htm SC 13G 11459
  Complete submission text file 0001104659-24-021727.txt   13020
Mailing Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600
Business Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600 6106691000
VANGUARD GROUP INC (Filed by) CIK: 0000102909 (see all company filings)

EIN.: 231945930 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Subject) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91525 | Film No.: 24629258
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)